DRIVE Expert Advisory Board and General Assembly meeting held in RCSI Dublin
The DRIVE project is over half way through, and approaching a critical stage of development for the diabetes reversing implant technologies. As such, it was a good time to get expert advice from leaders in the fields of cell therapy, devices, trials, regulation and finance to maximise the outputs from future project work. DRIVE's Expert Advisory Board were invited to RCSI Dublin, where after hearing a review of the project achievements and future work plans, they provided feedback and recommendations to the DRIVE General Assembly. The External Advisory Board was composed of Prof Paul de Vos (Professor of Immunoendocrinology, Faculty of Medical Sciences, University of Groningen), Dr Jeffrey Millman (Assistant Professor of Medicine and Biomedical Engineering, School of Medicine, Washington University in St. Louis), Dr Albert Hwa (Operations Director at Joslin Diabetes Center and Lecturer, Harvard Medical School), Dr Georgina Murphy (Investment Associate, Atlantic Bridge Capital) and Dr Niamh Curran (Pharmaceutical Assessor, Health Products Regulatory Authority).